Home > Healthcare > Medical Devices > Diagnostic Devices > Interventional Radiology Market

Interventional Radiology Market Share

Report ID: GMI3576
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Interventional Radiology Market Share

The market is characterized by the presence of several key players and a focus on technological innovation and strategic partnerships. Companies are investing in AI-driven technologies that provide deeper insights into diagnosis, disease patterns and patient outcomes. Additionally, there is a growing focus on diagnostic solutions with healthcare devices, systems, and software, and procedures to enable timely and accurate outcomes.

Interventional Radiology Market Companies

Prominent players operating in the interventional radiology industry include:

Agfa-Gevaert Group
Canon Medical Systems Corporation
Carestream Health Inc.
Cook
Esaote SPA
Fujifilm Corporation
GE Healthcare
Hologic, Inc.
Koninklijke Philips N. V
Olympus Corporation
Samsung Healthcare (Samsung Electronics Co., Ltd.)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shimadzu Corporation
Siemens Healthineers
Teleflex Incorporated

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The interventional radiology industry was valued at USD 28.1 billion in 2023 and is expected to exhibit 5% CAGR from 2024 – 2032 due to rising prevalence of chronic disease worldwide and increasing demand for minimally invasive procedures

The cardiology application segment held 31% of the market share in 2023 led by significant demand for diagnostic and therapeutic interventions.

The hospitals segment in the interventional radiology market is anticipated to reach USD 22.8 billion by 2032 as they are equipped with the most advanced and comprehensive infrastructure, including state-of-the-art imaging technologies and interventional radiology suites.

North America market is anticipated to grow at 4.3% CAGR between 2024 and 2032 led by a high prevalence of chronic conditions such as cardiovascular disease, cancer, and diabetes